Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
The Prostate
|
August 4, 1998
In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions
C Pföhler, T Fixemer, V Jung, et al.
The British Journal of Dermatology
|
May 13, 2005
Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV
G Ladewig, U Reinhold, C E Thirkill, et al.
Anticancer Research
|
August 5, 2006
Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro
B Shannan, M Seifert, K Leskov, et al.
Anticancer Research
|
August 12, 2009
Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients
B Nürnberg, S Gräber, B Gärtner, et al.
The British Journal of Dermatology
|
August 2, 2003
Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma
C Pföhler, A Haus, A Palmowski, et al.
Allergy
|
February 17, 2012
Symptom profile and risk factors of anaphylaxis in Central Europe
M Worm, G Edenharter, F Ruëff, et al.
Allergy
|
January 14, 2015
Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use
K Breuer, C Lipperheide, U Lipke, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 8, 2025
Trends in seafood-induced anaphylaxis: Data from the European Anaphylaxis Registry
L Faust, S Dölle-Bierke, D Sabouraud-Leclerc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
S Ugurel, D Schadendorf, K Horny, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
The Prostate
|
August 4, 1998
In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions
C Pföhler, T Fixemer, V Jung, et al.
The British Journal of Dermatology
|
May 13, 2005
Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV
G Ladewig, U Reinhold, C E Thirkill, et al.
Anticancer Research
|
August 5, 2006
Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro
B Shannan, M Seifert, K Leskov, et al.
Anticancer Research
|
August 12, 2009
Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients
B Nürnberg, S Gräber, B Gärtner, et al.
The British Journal of Dermatology
|
August 2, 2003
Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma
C Pföhler, A Haus, A Palmowski, et al.
Allergy
|
February 17, 2012
Symptom profile and risk factors of anaphylaxis in Central Europe
M Worm, G Edenharter, F Ruëff, et al.
Allergy
|
January 14, 2015
Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use
K Breuer, C Lipperheide, U Lipke, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 8, 2025
Trends in seafood-induced anaphylaxis: Data from the European Anaphylaxis Registry
L Faust, S Dölle-Bierke, D Sabouraud-Leclerc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
S Ugurel, D Schadendorf, K Horny, et al.
Page
of 4